POMALYST (pomalidomide) Patient Assistance Program
Don’t let the high cost of brand specialty myeloma therapy stand between you and the treatment you need. We help eligible patients access Pomalyst (pomalidomide) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Pomalyst (pomalidomide) is FDA-approved in combination with dexamethasone for adults with multiple myeloma who have received at least two prior therapies (including lenalidomide and a proteasome inhibitor) and have demonstrated disease progression on or within 60 days of the last therapy.
- Without assistance, the brand list price is approximately $24,500 per 21-capsule cycle at any of the 1 mg, 2 mg, 3 mg, or 4 mg strengths.
- Through AffordMyPrescriptions, qualifying patients can access Pomalyst (or generic pomalidomide) for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, REMS-program steps, and renewal process.
- Generic pomalidomide is now FDA-approved as bioequivalent to brand Pomalyst, and is typically available at meaningfully lower out-of-pocket cost; substitution depends on your prescriber and pharmacy.
What is Pomalyst Prescription Assistance Program?
The Pomalyst Prescription Assistance Program is a manufacturer-sponsored initiative that provides Pomalyst at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for myeloma patients who are uninsured or underinsured, as well as Medicare Part D beneficiaries who cannot afford brand specialty therapy.
Navigating the program on your own means dealing with eligibility verification, oncology-team coordination, REMS-program enrollment, pregnancy-test/contraception requirements, specialty pharmacy logistics, and renewal deadlines — all while managing relapsed or refractory myeloma.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through REMS-program coordination, refill scheduling, and annual re-certification — so you focus on your treatment, not paperwork.
Pharmacy Price Comparison
- Without assistance, brand Pomalyst costs approximately $24,500 per 21-capsule cycle. Generic pomalidomide is now available at significantly lower cost. Discount coupons offer some relief, but a Patient Assistance Program is the meaningful path for brand pricing — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$24,800.00 | Save ~$24,730/cycle |
| CVS Pharmacy | ~$25,000.00 | Save ~$24,930/cycle |
| Walmart | ~$24,200.00 | Save ~$24,130/cycle |
| Specialty Pharmacy (brand) | ~$24,500.00 | Save ~$24,430/cycle |
| Generic pomalidomide | ~$15,000+ | Cheaper than brand |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. Afford My Prescriptions Advocacy Service bypasses retail pricing by using drug manufacturer programs to secure your medication for you—independent of dosage or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Pomalyst Prescription Program?
The Patient Assistance Program is free to apply for and provides Pomalyst at little or no medication cost if approved. But the process involves detailed applications, oncology-team coordination, REMS-program enrollment with strict pregnancy-test and contraception requirements, specialty pharmacy logistics, and ongoing renewal management. Our $69.95/month service covers full advocacy: applications, doctor coordination, REMS coordination, documentation, refill management, and annual re-enrollment — so you focus on your treatment, not paperwork.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Pomalyst:
Limitations of Coupons
Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
Coupon cards expire and require constant renewal
Still $24,500 (brand) / ~$15,000+ (generic) per month even with the best discount
Cannot be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
Medicare Part D patients accepted
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Pomalyst assistance.
- You are a U.S. citizen or legal resident
- You Have A Valid Pomalyst Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Pomalyst:
Pomalyst (pomalidomide) is an oral immunomodulatory medicine used in combination with dexamethasone to treat adults with multiple myeloma whose cancer has come back or has not responded to earlier therapies. It is taken as a once-daily capsule on a 28-day cycle and is dispensed only through a restricted REMS program because of the risk of severe birth defects.
How It Works:
Pomalyst is a third-generation immunomodulatory drug that disrupts the supportive signals multiple myeloma cells need to survive and grow. It works on several fronts by directly slowing cancer cell division, reducing the blood supply to tumors, and stimulating the immune system to attack the cancer. Additionally, it interferes with the growth factors and bone marrow interactions that help the disease progress.
Form and Use:
The standard treatment schedule involves taking a 4 mg capsule once daily for the first 21 days of a 28-day cycle, followed by a seven-day break. This cycle repeats until the disease progresses, though starting doses may be lowered for patients with kidney issues or other medical factors. It is essential to follow this specific “on-and-off” schedule as directed by your oncology team.
Generic Availability:
Generic pomalidomide is FDA-approved and currently available in the U.S. as a bioequivalent alternative to brand-name Pomalyst. While the generic version typically offers a meaningfully lower out-of-pocket cost, both remain expensive specialty medications. Whether you receive the brand or generic version depends on your insurance coverage, pharmacy, and the specific preference of your prescriber.
Warnings:
Pomalyst carries a serious risk of severe birth defects and is only available through a restricted REMS program, which requires strict contraception and pregnancy testing. Other significant warnings include the risk of blood clots, low blood counts, liver toxicity, and the potential development of second cancers. Your medical team will perform regular lab work to monitor your health and manage these risks throughout your therapy.
FAQ (Frequently Asked Questions)
How Much Does Pomalyst Cost Without Insurance?
The brand list price is approximately $24,500 per 21-capsule cycle. Generic pomalidomide is FDA-approved and typically available at meaningfully lower out-of-pocket cost. Through AffordMyPrescriptions, qualifying patients receive Pomalyst (or generic pomalidomide) at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
What Is The Pomalyst REMS Program?
Pomalyst is dispensed only through a restricted Risk Evaluation and Mitigation Strategy (REMS) program because of the risk of severe birth defects. The REMS requires prescriber and pharmacy certification, specific pregnancy-test and contraception requirements for patients of childbearing potential, and other safe-use provisions. Your oncology team and pharmacist will walk you through the specific steps.
Is Generic Pomalidomide The Same Medicine?
Yes. Generic pomalidomide is FDA-approved as bioequivalent to brand Pomalyst, meaning the active ingredient and performance are the same. Whether your prescription is filled as brand or generic depends on your prescriber’s preference, your insurance plan, and the specialty pharmacy. We mention this directly because if generic pomalidomide is meaningfully cheaper for you (with or without our service), that may be the better path.
Can I Get Pomalyst Through The PAP If I Have Medicare?
Yes. Medicare Part D beneficiaries can typically qualify for Pomalyst Patient Assistance, especially if you face specialty-tier copays you cannot afford. The manufacturer’s commercial copay assistance program ($0 per month, up to ~$15,000/year) is reserved for commercially insured patients only — but the underlying PAP supports Medicare patients who meet income criteria.
What If My Application Is Denied?
If your initial application is denied, we explore alternative savings paths on your behalf — including switching to generic pomalidomide on a different cost path, the manufacturer’s copay assistance program if you have commercial insurance, independent foundations such as the PAN Foundation, HealthWell Foundation, International Myeloma Foundation, Multiple Myeloma Research Foundation, or Leukemia & Lymphoma Society, or asking your oncology team whether a different myeloma combination would be appropriate. If we cannot find a path, you will not be charged our service fee.
How Long Does It Take To Get Approved?
Most enrolled patients receive their first Pomalyst shipment within two to four weeks of completing the documentation and the REMS-program steps. Timing depends on how quickly your oncology team returns the required forms and the specialty pharmacy completes intake.
Take Control of Your Medication Costs
If you are struggling with the high cost of Pomalyst, our team may be able to help you access assistance programs designed to make brand specialty myeloma therapy affordable. Check your eligibility today and take the first step toward predictable, sustainable treatment.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.